Navigation Links
Brett Thompson to Join Third Wave Bioactives as Sales Director
Date:6/26/2017

Third Wave Bioactives, LLC announces the addition of Brett Thompson. Brett joins the team today in role of Sales Director, focused on leading new business development and ensuring quality customer experience.

Brett brings to Third Wave Bioactives more than 10 years of experience in the food ingredient industry in technical, marketing and sales roles. “Brett’s background working with customers and eye for market opportunities make him a great asset to help drive Third Wave’s growth. We are excited to add him to our team and look forward to the future,” said Matt Hundt, President of Third Wave Bioactives.

Third Wave Bio’s current commercial line of products, bioVONTAGE™, is a range of cultured dextrose and whey-based products that help food manufacturers develop unique flavor profiles while maintaining shelf-life, helping their customers meet growing opportunities in the food industry.

Located in the Technology Innovation Center in the Milwaukee County Research Park, Third Wave Bioactives provides clean label solutions for the food industry. To lean more visit http://www.thirdwavebio.com

About Third Wave Bioactives
Third Wave Bio is focused on developing novel, science-based, microbial solutions for the food and pet industries.  Our bioVONTAGE cultured dextrose products are designed to enhance the flavor profile of perishable foods while maintaining product quality, helping customers adapt to meet the growing consumer demand for healthier, cleaner labeled foods. Our open innovation platform and collaborative team make product selection and project engagement simple. For more information visit http://www.thirdwavebio.com

Read the full story at http://www.prweb.com/releases/2017/06/prweb14457856.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. New form of sedation now available in Fargo from Vance Thompson Vision
2. UBM and Massachusetts Medical Device Industry Council (MassMEDIC) Partner for Third Annual Massachusetts Medtech Week
3. Science Center’s Digital Health Accelerator Accepting Applications for Third Class
4. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017
5. OEMs Declare Creation Technologies Overall EMS Winner of Coveted Circuits Assembly Award for Third Consecutive Year
6. PTC Therapeutics Announces Third Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy
7. Tikcro Technologies Reports Third Quarter 2016 Results
8. GENEWIZ Chosen For The Inc. 5000 List Of Fastest-Growing Private Companies For Third Year In A Row
9. Ascendis Pharma A/S to Report Third Quarter 2016 Financial Results and Host Conference Call on November 30
10. Biorem Reports Third Quarter Results and Net Earnings of $0.02 per share
11. Merrimack Reports Third Quarter 2016 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World ... Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, ... an elite awards program, highlighting outstanding examples of how technology innovations and strategic ...
(Date:7/1/2020)... , ... June 29, 2020 , ... ... to competitively procured purchasing contracts to its membership, recently named BioFit Engineered ... members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading ... Space™ for businesses of all types to ensure cleanliness, distancing and occupancy with its ... A Safe Space™ enabled business will provide a health performance index system that scores ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... therapy for treating cancer, today announced the company has entered a license agreement ... The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding ...
Breaking Biology Technology:
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., ... the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New ... treatment of severe COVID-19. Approval of this IND allows Sentien to initiate a ...
(Date:8/12/2020)... ... 12, 2020 , ... Mosio recently announced its newly updated ... agencies of all sizes. With a focus on tracking symptoms and monitoring outbreaks ... care, Mosio helps public health departments automate communications and provide more personalized care ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
Breaking Biology News(10 mins):